| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Kumar Budur is Chief Medical Officer at HRMY. Kumar Budur's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $486K at current prices.
The HRMY filings lean toward selling, a net 72,406 shares.
Kumar Budur has 8 Form 4 filings on record from January 2024 to September 2026, all as Chief Medical Officer at Harmony Biosciences (HRMY), 2024–2026.
The 33 reported transactions were 13 option exercises, 8 option or other derivative awards, 7 open-market sales and 5 tax withholdings.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $3.1M.
The largest open-market sale was 38,452 shares of HRMY at an average $43.05 on September 18, 2026, about $1.7M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.